Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Kronbichler Andreas) > Prophylactic and ea...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		04180naa a2200481 4500
001		oai:DiVA.org:liu-196127
003		SwePub
008		230706s2023 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
009		oai:prod.swepub.kib.ki.se:152919922
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1961272 URI
024	7	a https://doi.org/10.1093/ndt/gfad0442 DOI
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1529199222 URI
040		a (SwePub)liud (SwePub)ki
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Hilhorst, Marcu Univ Amsterdam, Netherlands4 aut
245	1 0	a Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)
264		c 2023-03-06
264	1	b OXFORD UNIV PRESS,c 2023
338		a print2 rdacarrier
520		a The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic led to rapid vaccine development and large global vaccination schemes. However, patients with immune-mediated kidney disease, chronic kidney diseases and kidney transplant recipients show high non-response rates to vaccination despite more than three vaccinations and, consequently, reduced viral clearance capacity when infected while receiving certain immunosuppressants, carrying an elevated risk for coronavirus disease 2019 (COVID-19)-related morbidity and mortality. SARS-CoV-2 evolution has been characterized by the emergence of novel variants and spike mutations contributing to waning efficacy of neutralizing antibodies. To this end, the therapeutic field expands from vaccination towards a combined approach of immunization, pre-exposure prophylaxis and early post-exposure treatment using direct-acting antivirals and neutralizing monoclonal antibodies to treat early in the disease course and avoid hospitalization. This expert opinion paper from the Immunonephrology Working Group of the European Renal Association (ERA-IWG) summarizes available prophylactic and/or early treatment options (i.e. neutralizing monoclonal antibodies and direct-acting antivirals) of SARS-CoV-2-infected patients with immune-mediated kidney disease, chronic kidney disease and kidney transplant recipients.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng
653		a antiviral therapy; COVID-19; kidney; prophylaxis; transplantation
700	1	a Bemelman, Frederike J.u Univ Amsterdam, Netherlands4 aut
700	1	a Bruchfeld, Annetteu Karolinska Institutet,Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Univ Hosp, Sweden; CLINTEC Karolinska Inst, Sweden4 aut0 (Swepub:liu)anbru14
700	1	a Fernandez-Juarez, Gema M.u Hosp Univ Fdn Alcorcon, Spain4 aut
700	1	a Floege, Juergenu RWTH Aachen Univ Hosp, Germany4 aut
700	1	a Frangou, Eleniu Limassol Gen Hosp, Cyprus; Univ Nicosia, Cyprus4 aut
700	1	a Goumenos, Dimitriosu Patras Univ Hosp, Greece4 aut
700	1	a van Kooten, Ceesu Leiden Univ, Netherlands4 aut
700	1	a Kronbichler, Andreasu Univ Cambridge, England4 aut
700	1	a Stevens, Kate Iu Queen Elizabeth Univ Hosp, Scotland4 aut
700	1	a Turkmen, Kultiginu Necmettin Erbakan Univ, Turkiye4 aut
700	1	a Wiersinga, W. Joostu Univ Amsterdam, Netherlands4 aut
700	1	a Anders, Hans-Joachimu Hosp Ludwig Maximilians Univ, Germany4 aut
710	2	a Univ Amsterdam, Netherlandsb Avdelningen för diagnostik och specialistmedicin4 org
773	0	t Nephrology, Dialysis and Transplantationd : OXFORD UNIV PRESSg 38:8, s. 1807-1816q 38:8<1807-1816x 0931-0509x 1460-2385
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-196127
856	4 8	u https://doi.org/10.1093/ndt/gfad044
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:152919922

Hitta via bibliotek

Nephrology, Dialysis and Transplantation (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Hilhorst, Marc; Bemelman, Freder ...; Bruchfeld, Annet ...; Fernandez-Juarez ...; Floege, Juergen; Frangou, Eleni; visa fler...; Goumenos, Dimitr ...; van Kooten, Cees; Kronbichler, And ...; Stevens, Kate I; Turkmen, Kultigi ...; Wiersinga, W. Jo ...; Anders, Hans-Joa ...; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Urologi och njur ...

Artiklar i publikationen: Nephrology, Dial ...

Av lärosätet: Linköpings universitet; Karolinska Institutet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se